Sana Biotechnology, Inc.
SANA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$266,759 | -$283,255 | -$269,476 | -$355,928 |
| Dep. & Amort. | $17,391 | $24,557 | $15,625 | $11,070 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $37,678 | $35,533 | $38,337 | $22,362 |
| Change in WC | -$1,185 | $18,611 | $7,542 | $9,801 |
| Other Non-Cash | -$10,278 | -$49,028 | -$82,078 | $61,641 |
| Operating Cash Flow | -$223,153 | -$253,582 | -$290,050 | -$251,054 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$20,032 | -$20,876 | -$29,862 |
| Net Acquisitions | $0 | -$192 | -$231 | $0 |
| Inv. Purchases | $0 | -$157,744 | -$78,688 | -$491,387 |
| Inv. Sales/Matur. | $0 | $349,788 | $310,126 | $280,025 |
| Other Inv. Act. | $17,453 | $192 | $231 | -$4,574 |
| Investing Cash Flow | $17,453 | $172,012 | $210,562 | -$245,798 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $7,744 | $0 | $0 | $0 |
| Stock Issued | $181,000 | $31,646 | $4,913 | $631,751 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $11,005 | $0 | $0 | $0 |
| Financing Cash Flow | $199,749 | $31,646 | $4,913 | $631,751 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,951 | -$49,924 | -$74,575 | $134,899 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $137,349 | $187,273 | $261,848 | $126,949 |
| End Cash | $131,398 | $137,349 | $187,273 | $261,848 |
| Free Cash Flow | -$256,583 | -$273,614 | -$310,926 | -$280,916 |